SNCA and Parkinsonism: Specialised imaging modalities, particularly nuclear imaging and magnetic resonance imaging, and biomarkers of α-synuclein pathology demonstrate high sensitivity and specificity for not only early diagnosis but also differential diagnosis between other parkinsonisms.